Human Defensins: Structure, Function, and Potential as Therapeutic Antimicrobial Agents with Highlights Against SARS CoV-2
Open Access
- 18 December 2024
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17 (3) , 1563-1583
Abstract
The human defensins are a group of cationic antimicrobial peptides that range in size from 2 to 5 kDa and share a common structural motif of six disulphide-linked cysteines. Several naturally occurring human α- and β-defensins have been identified over the past two decades. They have a wide variety of antimicrobial effects, and their potential to avoid the development of resistance to antimicrobial treatment makes them attractive as therapeutic agents. Human defensins have recently been the focus of medical and molecular biology studies due to their promising application in medicine and the pharmaceutical industry. This work aims to provide a comprehensive summary of the current developments of human defensins, including their identification, categorization, molecular features, expression, modes of action, and potential application in medical settings. Current obstacles and future opportunities for using human defensins are also covered. Furthermore, we shed light on the potential of this class as an antiviral agent, particularly against SARS CoV-2, by providing an in silico-based investigation of their plausible mechanisms of action.Keywords
This publication has 148 references indexed in Scilit:
- Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient deliveryPharmacological Reports, 2022
- A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogensCellular and Molecular Life Sciences, 2022
- N‐terminal acetylation of antimicrobial peptide L163 improves its stability against protease degradationJournal of Peptide Science, 2021
- Antimicrobial peptides under clinical investigationPeptide Science, 2019
- Cyclization of the Antimicrobial Peptide Gomesin with Native Chemical Ligation: Influences on Stability and BioactivityChemBioChem, 2013
- Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activityArchives of Virology, 2009
- Antimicrobial Peptides: An Essential Component of the Skin Defensive Barrier2006
- Widespread expression of beta‐defensin hBD‐1 in human secretory glands and epithelial cellsFEBS Letters, 1996
- hBD‐1: a novel β‐defensin from human plasmaFEBS Letters, 1995
- Defensins promote fusion and lysis of negatively charged membranesProtein Science, 1993